Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Exelixis Inc
(NQ:
EXEL
)
22.51
-0.25 (-1.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,608,964
Open
22.76
Bid (Size)
22.33 (2)
Ask (Size)
22.75 (10)
Prev. Close
22.76
Today's Range
22.35 - 22.85
52wk Range
18.64 - 24.34
Shares Outstanding
315,048,788
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
7 Cheap Biotech Stocks With Major Upside Potential
July 09, 2024
While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks.
Via
InvestorPlace
When you look at NASDAQ:EXEL, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
June 27, 2024
When you look at EXELIXIS INC (NASDAQ:EXEL), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
Via
Chartmill
Performance
YTD
-5.93%
-5.93%
1 Month
+3.35%
+3.35%
3 Month
-1.57%
-1.57%
6 Month
-0.13%
-0.13%
1 Year
+16.63%
+16.63%
More News
Read More
Don't overlook NASDAQ:EXEL—it's a hidden gem with strong fundamentals and an attractive price tag.
June 06, 2024
Via
Chartmill
10 Health Care Stocks Whale Activity In Today's Session
May 31, 2024
Via
Benzinga
Over $8M Bet On This Health Care Stock? Check Out These 4 Stocks Insiders Are Buying
May 31, 2024
Via
Benzinga
The Analyst Verdict: Exelixis In The Eyes Of 5 Experts
May 01, 2024
Via
Benzinga
Technical Signals Point to a Possible Breakout for EXELIXIS INC.
April 24, 2024
Via
Chartmill
What Analysts Are Saying About Exelixis Stock
April 10, 2024
Via
Benzinga
Exelixis to Present at the William Blair 44th Annual Growth Stock Conference
May 28, 2024
From
Exelixis, Inc.
Via
Business Wire
Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
May 20, 2024
From
Exelixis, Inc.
Via
Business Wire
In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals.
May 15, 2024
Via
Chartmill
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
May 12, 2024
Via
The Motley Fool
MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths'
May 10, 2024
Via
Benzinga
Just Say No to Drugs: 3 Pharma Stocks to Avoid
May 08, 2024
Via
InvestorPlace
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
May 07, 2024
From
Exelixis, Inc.
Via
Business Wire
Exelixis (EXEL) Q1 2024 Earnings Call Transcript
May 01, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
EXEL Stock Earnings: Exelixis Misses EPS, Misses Revenue for Q1 2024
April 30, 2024
Via
InvestorPlace
Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update
April 30, 2024
From
Exelixis, Inc.
Via
Business Wire
The Top 3 Biotech Stocks to Buy in April 2024
April 27, 2024
Via
InvestorPlace
NASDAQ:EXEL is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
April 24, 2024
Via
Chartmill
Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
April 16, 2024
From
Exelixis, Inc.
Via
Business Wire
NASDAQ:EXEL is an undervalued gem with solid fundamentals.
March 29, 2024
Via
Chartmill
3 Biotech Stocks to Buy on the Dip: March 2024
March 27, 2024
Via
InvestorPlace
4 Magnificent Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
March 23, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024
March 09, 2024
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.